^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Esophageal Cancer
    Drug:paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Esophageal and Esophagogastric Junction Cancers: Preferred regimens…paclitaxel.